Deprescribing Fall Risk–Increasing Drugs in Older Adults: Implementation Challenges and a Conceptual Framework from the DeFRID Trial and Global Evidence

Clicks: 9
ID: 331779
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #168 of 170 articles by views in the journals of gerontology series a, biological sciences and medical sciences

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 170 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Deprescribing fall risk–increasing drugs (FRIDs) is essential for reducing polypharmacy and falls in older adults, yet randomized controlled trials (RCTs) face unique implementation challenges. The DeFRID study is an ongoing multi-center RCT evaluating an ARMOR-based deprescribing intervention versus usual care in adults aged ≥60 years prescribed FRIDs. The objectives of this review are threefold: (1) to describe practical challenges encountered during a multi-center deprescribing RCT in India; (2) to propose a conceptual framework for categorizing these barriers; and (3) to contextualize DeFRID's experience within the broader deprescribing research landscape. Methods We conducted a narrative review with systematic scoping elements, synthesizing global RCT evidence from PubMed, OpenAlex, and Google Scholar (inception–December 2025) with DeFRID process evaluation data. DeFRID barriers and facilitators were identified via mixed-methods (clinician KAP questionnaire and qualitative interviews), team meetings, retention logs, and Phase II RCT implementation data, thematically categorized, then compared with global RCT challenges. Results DeFRID implementation revealed four challenge categories: ethical–clinical difficulties establishing equipoise for FRID withdrawal; operational barriers to recruitment and retention; methodological complexities in fall outcome ascertainment; and context-specific constraints unique to the Indian LMIC setting—limited deprescribing guidelines, polypharmacy normalization, fragmented care coordination, and hierarchical decision-making. Global RCTs revealed substantial implementation challenges: low clinician adherence, short follow-up periods, restrictive eligibility excluding frail or cognitively impaired older adults, and resource-intensive interventions limiting scalability. Conclusions Deprescribing FRIDs in older adults is impeded by ethical, operational, methodological, and provider-patient challenges, necessitating multilevel strategies integrating training, shared decision-making, context-specific guidelines, and stakeholder engagement for scalable implementation.
Reference Key
openalex_W7220998132 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Madhavi Eerike, Sakthivadivel Varatharajan, Priyadharsini Rajendran, Paul Mathai, Veena Nayak, Vassiliki Karra, Gomathi Ramaswamy, Rekha Priyadarshini, Gerard Marshall Raj, Venugopalan Gunasekaran, Selvaraj Jayachandran, Sandhiya Selvarajan, Shivanand Kattimani, Anu Chandran, Rijesh Potangadi, Surendran Padinchara Kunhipilakkandiy, Narayanan Puthiya Veettil, Raghavendra A. Rao, Mukhyaprana M. Prabhu, Jerin Jose Cherian, Tanu Anand, Sowparnika Treasa Sabu, Lokesh Kumar Sharma
Journal the journals of gerontology series a, biological sciences and medical sciences
Year 2026
DOI
10.1093/gerona/glag248
URL
https://doi.org/10.1093/gerona/glag248
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.